Reordering the pecking order: management describes the company winning on a stage where it used to be too small to play
The model's full reasoning — Q2 2023 call → NOWe need to determine if management describes the company as now competing and winning at a level of the market that used to be above it. The key is a change in tier, already real, and early. Looking at the transcript, management discusses their strategy and progress. They mention expanding into translational and clinical markets, partnerships with biopharma, CROs, and diagnostic leaders. They talk about their CLIA Lab, companion diagnostic deals, and partnerships with Agilent, AstraZeneca, Acrivon. They also mention building a CRO network. However, do they explicitly say they are now competing at a higher tier than before? They talk about moving from discovery to translational and clinical, which is a progression. But is there a clear statement that they are now being considered for business they previously weren't? They mention "we continue to expand this ecosystem" and "our clinical market development and commercial team are leveraging the HT workflow improvements and best practices for advanced biopharma solutions, CLIA Lab or ABS to build a rapidly growing qualified CRO service provider network." That suggests they are building capabilities, but not necessarily that they have already won business at a higher tier. They also mention "securing our first companion diagnostic deal" - that is a specific achievement. But is that a change in tier? Possibly, but it's one deal. They also talk about "transformative partnerships with true thought leaders, including Agilent, AstraZeneca, Acrivon" - these are major players. But are they saying they are now competing with them? They are partnering, not necessarily displacing. The question asks: does management convey that the company has recently begun to be treated as a legitimate contender in situations, against rivals, or for business that previously would have gone to bigger, more established, or more entrenched players, and that this has already produced real results in the current period? I don't see a clear statement that they have moved up a tier. They talk about their strategy and progress, but they don't explicitly say "we are now winning business we couldn't before" or "we are now being considered for deals that used to go to others." They mention their installed base and growth, but that's not necessarily a tier change. Also, they are already a leader in spatial biology with the largest installed base.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
PRIM · Q2 2018 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing exactly this tier shift in the T&D segment: after the Willbros acquisition, the group “has been able to sign new awards with customers that have been hesitant because of previous concerns about their financial viability” and has received work from “some of the largest electrical utilities in the country.” David King notes that the work “outpaces anything he has seen in his 40-plus years,” and Pete Moerbeek adds that the one-year MSA revenue alone is now $1.1 million. Management presents these wins as a direct result of Primoris’s financial strength and parent-company backing, which previously excluded the T&D business from the largest accounts. The commentary frames the development as newly enabled and still early (only one month of T&D performance), satisfying all three required elements: a clear change in competitive tier, real business already won, and contribution still incremental relative to the company’s prior scale.
SANG · Q2 2024 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing a shift to competing at a higher tier with sophisticated mid-market clients through bundled offerings, illustrated by a recent win with a statewide park department that larger vendors couldn't serve affordably. They explicitly note this represents a change in tier ("the type of client the bundled capabilities of Sangoma can reach ... Sangoma is well positioned to play in both the small market and more sophisticated mid-market") and that it has already produced real results ("this recent win"), while conveying it is early ("there'll be a lag before it delivers material results.
WD · Q2 2022 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management explicitly describing a tier shift: from competing "predominantly with the likes of JPMorgan and Wells Fargo" to "going head-to-head with CBRE and JLL," enabled by technology investments that now allow them to "successfully compete against these much larger firms.